Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Participants
A Phase I, Single-Centre, Open-Label, Parallel, Two Dose Level Study to Investigate the Pharmacokinetics, Safety, and Tolerability Following a Single Dose of Baloxavir Marboxil in Healthy Chinese Volunteers
Sponsor: Hoffmann-La Roche
A NA clinical study on Healthy Volunteer, this trial is completed. The trial is conducted by Hoffmann-La Roche and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Mar 2022 — Dec 2022 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Jan 2022 — Mar 2022 [monthly]
Completed NA
-
Jan 2021 — Jan 2022 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
-
Jul 2020 — Sep 2020 [monthly]
Completed NA
-
Sep 2019 — Jul 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
- Shionogi
For direct contact, visit the study record on ClinicalTrials.gov .